Recombinant human growth hormone (GH) therapy in adults with age-related GH deficiency

BlueCross BlueShield Association
Record ID 32003000731
Authors' objectives:

This Assessment examines the available evidence to determine the effects of recombinant human growth hormone (rhGH) therapy on the health outcomes of aging adults who do not have organic or congenital causes of growth hormone deficiency.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Adult
  • Aged
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
Contact Email:
Copyright: BlueCross BlueShieldAssociation (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.